Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department
ORIGINAL RESEARCH — Volume 17 — February 13, 2020
PEER REVIEWED
Of patients assessed, 102 had LTBI. A total of 24 were excluded: 11 were treated previously; 4 were pregnant; 8 had contraindications, allergies, or unacceptable drug interactions; and 1 was unable to start treatment because of a move out of the state. Twenty-six patients declined to participate and received treatment through the local health department; 41 consented to participate. Eleven patients refused treatment, 1 never started treatment, and 40 initiated treatment at the pharmacy and were included in this study.
Figure.
Flow diagram for patient enrollment, study on using a collaborative care model to treat LTBI, New Mexico, 2017–2018. Abbreviation: LTBI, latent tuberculosis infection.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.